Peter Schulz-Knappe
13Patents
4h-index
29Co-inventors
60Inventor score
Filing activity: May 12, 1995 → Jul 6, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5744444A | HPTH-fragment-(1-37), the preparation thereof, medicaments containing same and the use thereof | Human Necessities | 22 | Expired |
| US5891904A | Use of inhibitors of phosphodiesterase IV | Human Necessities | 13 | Expired |
| US6875616B1 | Process for determining the status of an organism by peptide measurement | Emerging Cross-Sectional Technologies | 9 | Expired |
| US6180773A | Tandem cDNAs encoding chemokines CC-1, CC-2, and CC-3 | Human Necessities | 4 | Expired |
| US6083483A | Inhibitors of phosphodiesterase IV for x-ray imaging | Human Necessities | 2 | Expired |
| US10976321B2 | Mass spectrometric quantitation | Emerging Cross-Sectional Technologies | 0 | Active |
| US10060911B2 | Method for diagnosis of high-affinity binders and marker sequences | Physics | 0 | Active |
| US11320438B2 | Isotopic methods for measurement of tryptophan and metabolites thereof | Physics | 0 | Active |
| US10746735B2 | Marker sequences for diagnosing and stratifying SLE patients | Physics | 0 | Active |
| US11609237B2 | Marker sequences for diagnosing and stratifying systemic sclerosis patients | Physics | 0 | Active |
| US10571477B2 | Marker sequences for diagnosing and stratifying systemic sclerosis patients | Physics | 0 | Active |
| US11860162B2 | Marker sequences for diagnosing and stratifying SLE patients | Physics | 0 | Active |
| US9470692B2 | Mass spectrometric analysis | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.